Counseling among transmasculine adolescents who use depot medroxyprogesterone
Awarded 2022
In their hands: Exploring the potential of self-administered injectable contraception
Nancy Fang, MD, MS
University of Colorado, Denver

Recommendations regarding contraceptive counseling and reproductive health differ amongst transgender and gender diverse (TGD) youth compared to cis-gender youth. TGD youth face unique health disparities including increased risk of sexually transmitted infections, sexual abuse and violence, and unwanted pregnancies. TGD youth also face inequities within the healthcare system including lack of access to providers and delay or avoidance of care. Both patients and providers also have misconceptions around pregnancy risk in transgender individuals assigned female at birth (AFAB) who are sexually active with people assigned male at birth. Limited existing literature demonstrates the need for contraceptive counseling that moves beyond cis- and heteronormative assumptions that start with pregnancy prevention and addresses concerns at the intersection of gender identity.

Our qualitative study will focus on creating best practices regarding equitable contraceptive counseling for TGD youth. We will recruit transgender youth who are AFAB, and currently or interested in using depo medroxyprogesterone (DMPA). Through focus groups and semi-structured interviews, we hope to gain the perspectives of and experiences of TGD youth with self- and clinic- administered DMPA. We hope the results of this study can guide providers in creating best practices and more equitable contraceptive counseling for TGD youth.